Massachusetts Institute Of Technology Bei Gene, Ltd. Transaction History

Massachusetts Institute Of Technology

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $318,858 - $573,768	-2,754 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$120.61 - $148.29 $332,159 - $408,390	2,754 New	2,754 $337,000
Q1 2019 May 14, 2019	SELL	$122.82 - $151.83 $941,906 - $1.16 Million	-7,669 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$107.01 - $175.15 $820,659 - $1.34 Million	7,669 New	7,669 $1.08 Million

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Massachusetts Institute Of Technology, based on Form 13F filings with the SEC.

Stay updated on Massachusetts Institute Of Technology with notifications on news.